These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6243673)

  • 1. Variable susceptibility of mice to group B coxsackievirus infections.
    Minnich LL; Ray CG
    J Clin Microbiol; 1980 Jan; 11(1):73-5. PubMed ID: 6243673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants.
    Gómez RM; Cui X; Castagnino CG; Berría MI
    Intervirology; 1993; 36(3):153-60. PubMed ID: 8150596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.
    Wolfgram LJ; Beisel KW; Herskowitz A; Rose NR
    J Immunol; 1986 Mar; 136(5):1846-52. PubMed ID: 3005402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective polymyositis inducted by coxsackievirus B1 in mice.
    Ray CG; Minnich LL; Johnson PC
    J Infect Dis; 1979 Aug; 140(2):239-43. PubMed ID: 225392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Ochiai H; Sasayama S
    Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic differences between coxsackie A and B virus infections in newborn mice.
    Hyypiä T; Kallajoki M; Maaronen M; Stanway G; Kandolf R; Auvinen P; Kalimo H
    Virus Res; 1993 Jan; 27(1):71-8. PubMed ID: 8383395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.
    Kiel RJ; Smith FE; Chason J; Khatib R; Reyes MP
    Eur J Epidemiol; 1989 Sep; 5(3):348-50. PubMed ID: 2551723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign human enterovirus becomes virulent in selenium-deficient mice.
    Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
    J Med Virol; 1994 Jun; 43(2):166-70. PubMed ID: 8083665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction.
    Okada I; Matsumori A; Kyu B
    Int J Exp Pathol; 1992 Dec; 73(6):721-31. PubMed ID: 1337265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
    Chow LH; Gauntt CJ; McManus BM
    Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3.
    Huber SA; Job LP
    Infect Immun; 1983 Mar; 39(3):1419-27. PubMed ID: 6301994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.
    Hufnagel G; Chapman N; Tracy S
    Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains.
    Cao Y; Schnurr DP; Schmidt NJ
    Arch Virol; 1984; 80(2-3):119-30. PubMed ID: 6326709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.
    Schnurr DP; Schmidt NJ
    Med Microbiol Immunol; 1984; 173(1):1-7. PubMed ID: 6088960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.
    Huber SA; Polgar J; Schultheiss P; Schwimmbeck P
    J Virol; 1994 Jan; 68(1):195-206. PubMed ID: 8254729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viral genome in experimental murine Coxsackievirus B3 myocarditis: a Northern blotting analysis.
    Okada I; Matsumori A; Kawai C; Yodoi J; Tracy S
    J Mol Cell Cardiol; 1990 Sep; 22(9):999-1008. PubMed ID: 2177795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine acinar pancreatitis preceding necrotizing myocarditis after Coxsackievirus B3 inoculation.
    Gómez RM; Lascano EF; Berría MI
    J Med Virol; 1991 Oct; 35(2):71-5. PubMed ID: 1662707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection.
    Sun F; Li Y; Jia T; Ling Y; Liang L; Liu G; Chen H; Chen S
    Arch Virol; 2012 Jun; 157(6):1101-11. PubMed ID: 22426860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.